跳至主要内容
临床试验/NCT01887262
NCT01887262已完成不适用

Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS (COMPASS) Trial

Seoul National University Hospital2 个研究点 分布在 2 个国家目标入组 108 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
2
主要终点
delta GFR

研究概览

简要总结

Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better protection of residual renal function over 1 year period, compared with management guided by clinical information alone - such as blood pressure, body weight, and physician's physical examination.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age bwten 20 and 75
  • peritoneal dialysis > 4 weeks duration
  • written consent
  • daily urine output > 500 ml

排除标准

  • subjects who are contraindicated to the bioimpedance measurement (pacemaker insertion state, defibrillator state, amputee, prosthesis, metal implants)
  • pregnant women
  • subjects who are expected to discontinue peritoneal dialysis with one year
  • mixed dialysis modality (peritoneal + hemodialysis)
  • hypoalbuminemic subjects (serum albumin < 3.3 g/dL)
  • high blood pressure (> 160/100 mmHg despite antihypertensive medications)
  • severe heart failure (NYHA FC III, or IV)

结局指标

主要结局

delta GFR

时间窗: baseline and 12th month

change of glomerular filtration rate from baseline to the 12th month

次要结局

  • GFR(at 12th month)
  • time to anuria(over 12 months)
  • echocardiographic parameters(12 months period)
  • BP(12th month)
  • cardiovascular event(over 12 months)
  • BCM parameters(baseline and 12th month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kook-Hwan Oh

Associate Professor

Seoul National University Hospital

研究点 (2)

Loading locations...

相似试验

Control Of Fluid Balance Guided by Body Composition... | 临床试验